An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
NCT02503176 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2018-03-05
Summary
The purpose of this study is to evaluate of the long-term safety and efficacy of KCT-0809 in dry eye patients with Sjögren's syndrome.
Conditions
- Dry Eye With Sjögren's Syndrome
Interventions
- DRUG
-
KCT-0809 ophthalmic solution
Sponsors & Collaborators
-
Kissei Pharmaceutical Co., Ltd.
lead INDUSTRY
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Primary Completion
- 2017-05-29
Countries
- Japan
More Related Trials
-
A Study of KCT-0809 in Patients With Dry Eye Syndromes
NCT01211951 ·Status: COMPLETED ·Phase: PHASE2
-
MSCohi-O Lenses for Ocular Involvement in Sjögren's Syndrome
NCT07185139 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren Syndrome
NCT02011776 ·Status: COMPLETED
-
Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease
NCT03216096 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome
NCT07277257 ·Status: RECRUITING ·Phase: PHASE4
-
Exploratory Study for Dry Mouth in Patients With Sjögren's Syndrome
NCT00233363 ·Status: COMPLETED ·Phase: PHASE2
-
Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01101984 ·Status: COMPLETED ·Phase: NA
-
Exosomes in Patients With Ocular Involvement of Sjögren's Syndrome
NCT07192666 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease
NCT04084483 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety and Immunological Evaluation of Tofacitinib in the Treatment of Primary Sjogren's Syndrome
NCT05087589 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of 0.05% Cyclosporine A Eye Drops Combined With Absorbable Tear Duct Plugs in the Treatment of Dry Eye in Sjögren's Syndrom
NCT07171710 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
A Study of AG-80308 in Dry Eye Patients
NCT05372107 ·Status: COMPLETED ·Phase: PHASE1
-
Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome
NCT04819269 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Pharmacokinetics, and Preliminary Efficacy Study of CDZ173 in Patients With Primary Sjögren's Syndrome
NCT02775916 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye
NCT01488396 ·Status: COMPLETED ·Phase: PHASE4
-
DNase Treatment for Dry Eyes
NCT02193490 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Multi-Centre, Randomised, Controlled, Masked Phase 2 Study of the Safety and Efficacy of KIO-101 Ophthalmic Solution, Versus Vehicle Control in the Treatment of Dry Eye Disease in Patients With Autoimmune Disease
NCT05629364 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants
NCT05992922 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of SHR8028 Eye Drops for the Treatment of Dry Eye Disease
NCT05841043 ·Status: COMPLETED ·Phase: PHASE3
-
Differences in Corneal Structure and Function in Patients With Sjogrens vs. Non-Sjogrens Dry Eye
NCT06364657 ·Status: TERMINATED
-
A Safety and Efficacy Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's Syndrome
NCT00852839 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease
NCT04030962 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01189032 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes
NCT00721656 ·Status: COMPLETED ·Phase: PHASE2
-
Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests
NCT04125134 ·Status: TERMINATED ·Phase: PHASE4